1. Home
  2. MKTW vs CCEL Comparison

MKTW vs CCEL Comparison

Compare MKTW & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarketWise Inc.

MKTW

MarketWise Inc.

N/A

Current Price

$16.05

Market Cap

38.7M

Sector

Technology

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.65

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKTW
CCEL
Founded
1999
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7M
32.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
MKTW
CCEL
Price
$16.05
$3.65
Analyst Decision
Hold
Hold
Analyst Count
1
1
Target Price
$20.00
N/A
AVG Volume (30 Days)
8.0K
3.7K
Earning Date
11-06-2025
10-15-2025
Dividend Yield
5.00%
10.75%
EPS Growth
N/A
N/A
EPS
2.55
N/A
Revenue
$342,206,000.00
$31,747,500.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
$6.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.08
$3.57
52 Week High
$21.74
$8.79

Technical Indicators

Market Signals
Indicator
MKTW
CCEL
Relative Strength Index (RSI) 47.09 41.78
Support Level $15.90 $3.81
Resistance Level $16.65 $4.38
Average True Range (ATR) 0.37 0.28
MACD -0.04 -0.02
Stochastic Oscillator 9.24 22.22

Price Performance

Historical Comparison
MKTW
CCEL

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: